ClinicalTrials.gg
Enrolling by invitationNCT06072599Updated May 18, 2026

Use of Osteopathic Manipulative Treatment for Non-musculoskeletal Conditions

An observational study in Manipulation, Osteopathic, sponsored by A.T. Still University of Health Sciences. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by A.T. Still University of Health Sciences · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn how clinicians use osteopathic manipulative treatment (OMT) for their patients who have problems only related to their muscles, bones, and joints (ie, musculoskeletal problems) compared to patients whose problems involve other body systems (eg, infections, breathing, bowel function). The main questions it aims to answer are:

  • What percentage of patients receiving OMT have a non-musculoskeletal problem?
  • Is there a difference in the OMT techniques when the patient's problems include a non-musculoskeletal problem compared to patients with only musculoskeletal problems?

Surveys will be completed by the clinicians about 20 unique adult (age 18 or older) patients who have received OMT.

02

Conditions studied

  • Manipulation, Osteopathic

Keywords

  • Musculoskeletal Diseases
  • Non-Musculoskeletal Diseases
  • Osteopathic Manipulative Treatment
03

In context

Musculoskeletal Diseases

752 studies on the registry are indexed under Musculoskeletal Diseases; 164 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 120 across 207 observational studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

A.T. Still University of Health Sciences is the lead sponsor of 20 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients receiving osteopathic manipulative treatment globally either in an outpatient or inpatient setting.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients receiving osteopathic manipulative treatment from a participating treatment provider

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Type of chief complaint

    Multiple choice question: Do this patient's chief complaints include musculoskeletal complaints only, non-musculoskeletal complaints only, or both musculoskeletal and non-musculoskeletal complaints?

    Time frame: 24 hours

  2. Osteopathic manipulative treatment techniques

    Multiple choice question (multiple answers): What OMT techniques did you use to treat this patient's somatic dysfunction? (list of 12 OMT technique categories)

    Time frame: 24 hours

07

Study locations

1 site
  • ATSU-KCOM OMM Clinic
    Kirksville, Missouri 63501, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2023 (actual). Primary completion is estimated for Sep 2026, 33 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2023
First posted
Oct 10, 2023
StartActual
Dec 1, 2023
Primary completionEst.
Sep 30, 2026
CompletionEst.
Sep 30, 2026
Last update
May 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06072599
Lead sponsor
A.T. Still University of Health Sciences
Collaborators
DO-Touch.NET
Responsible party
Sponsor
First posted
Oct 10, 2023
Start date
Dec 1, 2023
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
May 18, 2026

Study contacts

Jane C Johnson, MA
principal investigator · A.T. Still University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion